Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli

Protein Expression and Purification

Volumn 20, Issue 1, 2000, Pages 73-80

  Shimada, Tsutomu ^a   Tsumura, Fujiko ^a   Gillam, Elizabeth M J ^b   Guengerich, F Peter ^c   Inoue, Kiyoshi ^a  

^a OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN; ALLELE; BACTERIUM CELL; CATALYSIS; CELL MEMBRANE; CISTRON; COMPLEMENTARY DNA; CYTOCHROME P450; GENETIC VARIANCE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN PURIFICATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

EID: 0033815520     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2000.1302     Document Type: Article

References (46)

1. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1
2. Recombinant human cytochrome P450 1B1 expression in Escherichia coli
3. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1
4. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2
5. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21
6. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1
7. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia
8. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer
9. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations
10. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
11. Catalytic properties of polymorphic human cytochrome P450 1B1 variants
12. cDNA-expressed human cytochrome P450s: A new age of molecular toxicology and human risk assessment
13. New applications of bacterial systems to problems in toxicology
14. Stable expression of human cytochrome P450 1B1 in V79 chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene
15. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: Substrate specificity with model substrates and promutagens
16. Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions
17. Expression, purification, and characterization of a catalytivally active human cytochrome P450 1A2: Rat NADPH-cytochrome P450 reductase fusion protein
18. Drug metabolism by Escherichia coli expressing human cytochromes P450
19. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: Effects of contents of these two forms in individual human samples
20. Recombinant DNA technology as an investigative tool in drug metabolism research
21. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone using kinetic parameters of recombinant cytochrome P450 enzymes
22. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase
23. NADPH-cytochrome P-450 oxidoreductase. The role of cysteine 566 in catalysis and cofactor binding
24. Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities
25. Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles
26. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography
27. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction
28. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature
29. Protein measurement with the Folin phenol reagent
30. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis
31. Immunochemical study on the electron pathway from NADH to cytochrome P-450 of liver microsomes
32. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver
33. Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity
34. Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P450 reductase concentrations as factors in microsomal metabolism of warfarin
35. High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli
36. Cytochrome P450-containing oxygenase systems
37. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians
38. Purification and characterization of hepatic microsomal cytochrome P-450
39. 5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes
40. 5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2El and by human liver microsomes
41. 5
42. 5 interactions
43. Expression of modified human cytochrome P450 1A1 in Escherichia coli: Effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties
44. Expression of modified human cytochrome P450 1A2 in Escherichia coli. abilization, purification, spectral characterization, and catalytic activities of the enzymes
45. Conformation change of cytochrome P450 1A2 induced by phospholipids and detergents
46. 5 in microsomes